World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
55
Citations
15917
World Ranking
3777
National Ranking
1731

Keith A. Reimann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Keith A. Reimann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 128 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Keith A. Reimann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Keith A. Reimann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 55 D-Index — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Keith A. Reimann is affiliated with Harvard Medical School in the United States. Their primary field of research is Medicine, with specific focus areas including Surgery, Epidemiology, Developmental Neuroscience, Immunology, and Pathology and Forensic Medicine.

The main topics covered in their work include:

  • Anesthesia and Neurotoxicity Research
  • Organ Transplantation Techniques and Outcomes
  • Xenotransplantation and immune response
  • Cardiac Ischemia and Reperfusion
  • Viral-associated cancers and disorders
  • Cytomegalovirus and herpesvirus research
  • Parvovirus B19 Infection Studies

Some of the recent papers authored or co-authored by Keith A. Reimann are:

  • Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model, 2021, Cell Reports Medicine
  • Biophysical Evaluation of Rhesus Macaque Fc Gamma Receptors Reveals Similar IgG Fc Glycoform Preferences to Human Receptors, 2021, Frontiers in Immunology
  • Anti-thymoglobulin induction improves neonatal porcine xenoislet engraftment and survival, 2021, Xenotransplantation
  • SIV clearance from neonatal macaques following transient CCR5 depletion, 2023, bioRxiv (Cold Spring Harbor Laboratory)
  • Worldwide First Successful and Reproducable Long-Term Survival up to Half a Year: Completed Preclinical Study with Life-Supporting Orthotopic Pig-to-Baboon Cardiac Xenotransplantation (oXHTx) Fullfilling the ISHLT Prerequisite for Clinical Cardiac Xenotransplantation, 2020, The Journal of Heart and Lung Transplantation

Frequent co-authors who have collaborated with Keith A. Reimann on multiple publications include:

  • Paolo Brenner
  • Bruno Reichart
  • Stefan Buchholz
  • Eckhard Wolf
  • David Ayares

The venues where Keith A. Reimann has published frequently are:

  • Cell Reports Medicine
  • Frontiers in Immunology
  • Xenotransplantation
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Heart and Lung Transplantation

Best Publications

  • Control of Viremia in Simian Immunodeficiency Virus Infection by CD8+ Lymphocytes

    Jörn E. Schmitz;Marcelo J. Kuroda;Sampa Santra;Vito G. Sasseville

  • CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection

    Robert Thimme;Stefan Wieland;Carola Steiger;John Ghrayeb

  • Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

    Z. Q. Zhang;T. Schuler;M. Zupancic;Stephen W Wietgrefe

  • Memory CD8+ T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection

    Naglaa H. Shoukry;Arash Grakoui;Michael Houghton;David Y. Chien

  • A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

    K A Reimann;J T Li;R Veazey;M Halloran

  • Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease

    Elizabeth M Race;Jennifer Adelson-Mitty;Gila R Kriegel;Tamar F Barlam

  • Smallpox vaccine–induced antibodies are necessary and sufficient for protection against monkeypox virus

    Yvette Edghill-Smith;Hana Golding;Jody Manischewitz;Lisa R King

  • Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO.hCD46.hTBM pig-to-primate cardiac xenograft

    Muhammad M. Mohiuddin;Avneesh K. Singh;Philip C. Corcoran;Marvin L. Thomas

  • Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques.

    K A Reimann;K Tenner-Racz;P Racz;D C Montefiori

  • An env gene derived from a primary human immunodeficiency virus type 1 isolate confers high in vivo replicative capacity to a chimeric simian/human immunodeficiency virus in rhesus monkeys.

    K A Reimann;J T Li;G Voss;C Lekutis

  • Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys.

    Y Yasutomi;K A Reimann;C I Lord;M D Miller

  • Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment

    Jeffrey D. Lifson;Jeffrey L. Rossio;Michael Piatak;Thomas Parks

  • Antiretroviral Activity of the Anti-CD4 Monoclonal Antibody TNX-355 in Patients Infected with HIV Type 1

    Daniel R. Kuritzkes;Jeffrey Jacobson;William G. Powderly;Eliot Godofsky

  • Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys.

    Gunilla B. Karlsson;Matilda Halloran;John Li;In Woo Park

  • CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

    Nancy J Sullivan;Lisa Hensley;Clement Asiedu;Thomas W Geisbert

  • Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak

    Zachary A. Bornholdt;Hannah L. Turner;Charles D. Murin;Wen Li

  • Effect of Humoral Immune Responses on Controlling Viremia during Primary Infection of Rhesus Monkeys with Simian Immunodeficiency Virus

    Jörn E. Schmitz;Marcelo J. Kuroda;Sampa Santra;Meredith A. Simon

  • Pathogenicity of Simian-Human Immunodeficiency Virus SHIV-89.6P and SIVmac Is Attenuated in Cynomolgus Macaques and Associated with Early T-Lymphocyte Responses

    Keith A. Reimann;Robert A. Parker;Michael S. Seaman;Kristin Beaudry

  • Effect of CD8+ Lymphocyte Depletion on Virus Containment after Simian Immunodeficiency Virus SIVmac251 Challenge of Live Attenuated SIVmac239Δ3-Vaccinated Rhesus Macaques

    Jörn E. Schmitz;R. Paul Johnson;Harold M. McClure;Kelledy H. Manson

  • Preservation of Lymphocyte Immunophenotype and Proliferative Responses in Cryopreserved Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus Type 1-Infected Donors: Implications for Multicenter Clinical Trials

    Keith A. Reimann;Miriam Chernoff;Cynthia L. Wilkening;Christine E. Nickerson

Frequent Co-Authors

Norman L. Letvin
Norman L. Letvin Beth Israel Deaconess Medical Center
Christian P. Larsen
Christian P. Larsen Emory University
David Ayares
David Ayares University of Maryland, Baltimore
Jörn E. Schmitz
Jörn E. Schmitz Harvard Medical School
David C. Montefiori
David C. Montefiori Duke University
Allan D. Kirk
Allan D. Kirk Duke University
Michelle A. Lifton
Michelle A. Lifton Beth Israel Deaconess Medical Center
Klara Tenner-Racz
Klara Tenner-Racz Bernhard Nocht Institute for Tropical Medicine
Eckhard Wolf
Eckhard Wolf Ludwig-Maximilians-Universität München
Paul Racz
Paul Racz Bernhard Nocht Institute for Tropical Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can broaden career opportunities in healthcare and biomedical fields. Many programs focus on fast-tracking education to meet industry demands. For example, those with non-nursing backgrounds can advance quickly by enrolling in 12-month accelerated nursing programs online for non nurses, enabling a swift transition into nursing roles.

Similarly, aspiring nursing professionals may consider 12-month accelerated nursing programs designed to combine intensive study with hands-on clinical experience. These programs are ideal for those who want to complete a Bachelor of Science in Nursing (BSN) in a reduced time frame.

For individuals seeking quicker entry into the healthcare sector, fastest and easiest lpn programs provide a streamlined path to becoming a Licensed Practical Nurse, which can complement further specialization in immunological research and patient care.

Moreover, advanced practitioners can elevate their careers through accelerated fnp programs, focusing on Family Nurse Practitioner roles with a strong clinical and immunological foundation. These pathways illustrate the diverse educational opportunities that support a robust career in immunology and healthcare.

Best Scientists Citing Keith A. Reimann

Trending Scientists

Recently Published Articles